Navigation Links
IDM Pharma Reports 2007 Financial Results
Date:3/20/2008

ment to the L-MTP-PE new drug

application, or NDA, to the FDA in the fourth quarter of 2008.

-- Updated Phase 3 data on L-MTP-PE was presented at the Connective

Tissue Oncology Society, or CTOS, meeting in November 2007. Also,

data from our L-MTP-PE compassionate use program was presented at the

November 2007 meeting of the International Society of Pediatric

Oncology, or SIOP.

-- Announced Phase 3 Mifamurtide (L-MTP-PE) study demonstrating improved

survival was published in the Journal of Clinical Oncology in February

2008. Children's Oncology Group report shows the addition of L-MTP-PE

to chemotherapy reduced the risk of death by 30% in osteosarcoma

patients.

-- In June 2007, we completed a registered direct offering of our common

stock, and warrants to purchase common stock, and received

approximately $25.0 million in gross proceeds, and finished 2007 with

$28.4 million, providing cash for operations into the first half of

2009.

"We made significant progress over the past year in our efforts to bring our lead product candidate, L-MTP-PE, to market in Europe," said Timothy P. Walbert, president and chief executive officer, IDM Pharma. "We are developing L-MTP-PE for the treatment of osteosarcoma, the most common type of bone cancer affecting adolescents. We believe our updated survival data from the L-MTP-PE Phase 3 trial, demonstrating statistically superior overall survival in long-term patient follow-up, were critical to the recent non-binding opinion of the Committee for Medicinal Products for Human Use in Europe that L-MTP-PE suggested a possible clinical benefit in terms of survival. We remain committed to resolving the remaining items of the L-MTP-PE European Marketing Authorization Application and working at the same time to advance this important potential treatment through its U.S. regulatory path.
'/>"/>

SOURCE IDM Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
5. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
8. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
9. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
11. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Bahama (PRWEB) May 05, 2015 Okyanos, ... Orthopedic Lifestyle Report today. The study was conducted to ... such as osteoarthritis and sports-related injuries have ... and stiffness was the most prevalent symptom reported at ... such as walking, standing and bending over. Over half ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 With ... Josie's Organics, one of the country's leading organic ... minds of moms across the country. What to ... family recipe box or spend hours browsing Pinterest ... on http://www.josiesorganics.com/recipes . , The new ...
(Date:5/5/2015)... 2015 In the upbeat Moms Helping Moms ... moms to support each other. Parenting is a tough ... makes it so much easier. Mothers talk about how ... less alone and help them realize there’s no perfect parent; ... who are clearly dear friends share that it's just that, ...
(Date:5/5/2015)... May is National Osteoporosis Month, and also marks ... Bone Health . Founded by Charles T. Price, MD, the ... and physicians about the latest advances in bone care, and ... to a study recently published by the Journal of Bone ... osteoporosis and low bone mass. This breaks down to a ...
(Date:5/5/2015)... St.Louis MO (PRWEB) May 05, 2015 ... innovative bar flavors in 2014, Walgreens introduces the Cookies ... By focusing on innovation, Extend Nutrition has continually raised ... achieved a great taste, combined with an unprecedented nutritional ... Building on this success, Extend Nutrition will launch additional ...
Breaking Medicine News(10 mins):Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 2Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 3Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 2Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 3Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 4Health News:Just In Time For Mother’s Day, Healthy Birth Day Releases Video Titled “Moms Helping Moms” Encouraging Mothers To Band Together 2Health News:The Institute for Better Bone Health Observes National Osteoporosis Month, Celebrates Three Years of Promoting Healthy Bones 2Health News:The Institute for Better Bone Health Observes National Osteoporosis Month, Celebrates Three Years of Promoting Healthy Bones 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 4
... in ovarian cancer has provided the most comprehensive and integrated ... Ovarian serous adenocarcinoma tumors from 500 patients were examined by ... reported in the June 30, 2011, issue of Nature ... of ovarian cancer, accounting for about 85 percent of all ...
... (HealthDay News) -- Obesity is a major risk factor ... women, a new study finds. It included more than ... smoked and were followed for 28 years. During that time, ... disease and 487 (27 percent) from cancer. Researchers found ...
... recent study accepted for publication in The Endocrine Society,s ... early, prolonged treatment with the diabetes drug metformin may prevent ... adolescence. PCOS affects 7 to 10 percent of ... of infertility, affecting an estimated 5 to 6 million women ...
... Reporter , TUESDAY, June 28 (HealthDay News) -- A vaccine ... some promise, while another designed to alter insulin production fails, ... results of both studies were slated to be presented Tuesday ... Type 1 diabetes often appears early in life and ...
... are teaming up to offer one of the nation,s ... trucks. Led by the University of Maryland and ... program will target the so-called short-haul "drayage" fleet that ... The effort seeks to double the impact ...
... TUESDAY, June 28 (HealthDay News) -- Mammography screening reduces breast ... according to a new, large-scale Swedish trial. In a ... longest ever -- the researchers found that the benefits of ... In fact, most of the benefits occur more than 10 ...
Cached Medicine News:Health News:The Cancer Genome Atlas completes detailed ovarian cancer analysis 2Health News:The Cancer Genome Atlas completes detailed ovarian cancer analysis 3Health News:Obesity a Major Cause of Early Death in Women: Study 2Health News:Diabetes drug may prevent or delay development of polycystic ovary syndrome 2Health News:Trials of Type 1 Diabetes Vaccines Bring Mixed Results 2Health News:Trials of Type 1 Diabetes Vaccines Bring Mixed Results 3Health News:Mid-Atlantic states' unique plan to replace region's dirtiest trucks 2Health News:Mid-Atlantic states' unique plan to replace region's dirtiest trucks 3Health News:Longest Trial Ever Confirms Mammograms' Benefits 2Health News:Longest Trial Ever Confirms Mammograms' Benefits 3
(Date:5/5/2015)... Research and Markets ( http://www.researchandmarkets.com/research/79lcd4/will_theranos ) ... Turn the Lab Industry Upside Down?" report to ... along with a healthy dose of skepticism in recent ... disruptive laboratory solution. Behind all of the press, there ... microfluidic technology across a comprehensive menu of tests? ...
(Date:5/4/2015)... Luminex Corporation (NASDAQ: LMNX ) today announced financial results ... operating highlights include the following: , Consolidated first ... the first quarter of 2014. , First quarter assay ... first quarter of 2014. , Consolidated gross profit margin ... , GAAP net income for the first quarter was $7.5 ...
(Date:5/4/2015)... , May 4, 2015  Neurocrine Biosciences, Inc. (NASDAQ: ... Aurora has joined the company as Vice President, ... to welcome Dr. Bill Aurora to the ... Kevin Gorman , President and Chief Executive Officer ... scientific exchange and outreach coupled with his extensive network ...
Breaking Medicine Technology:Will Theranos Turn the Lab Industry Upside Down? 2Luminex Corporation Reports First Quarter 2015 Results 2Luminex Corporation Reports First Quarter 2015 Results 3Luminex Corporation Reports First Quarter 2015 Results 4Luminex Corporation Reports First Quarter 2015 Results 5Luminex Corporation Reports First Quarter 2015 Results 6Luminex Corporation Reports First Quarter 2015 Results 7Luminex Corporation Reports First Quarter 2015 Results 8Luminex Corporation Reports First Quarter 2015 Results 9Luminex Corporation Reports First Quarter 2015 Results 10Luminex Corporation Reports First Quarter 2015 Results 11Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 2Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 3
... BERKELEY, Calif. , Aug. 5 Can neuroscience be used ... by the popular science weekly, New Scientist, to NeuroFocus, the world,s largest ... ... brainwave activity, NeuroFocus measured and analyzed their responses to three different cover ...
... , and AMSTERDAM , August 5, 2010 ... today announced the,inauguration of a new state-of-the-art clinical genomics ... laboratory were located in, Huntington Beach, CA. The ... commercial expansion in the U.S. market, as well as,the ...
Cached Medicine Technology:NeuroFocus and New Scientist Magazine Apply Neuromarketing to Select Cover Design 2NeuroFocus and New Scientist Magazine Apply Neuromarketing to Select Cover Design 3Agendia Inaugurates New State-of-the-Art Genomics Laboratory in Irvine 2Agendia Inaugurates New State-of-the-Art Genomics Laboratory in Irvine 3Agendia Inaugurates New State-of-the-Art Genomics Laboratory in Irvine 4
White Standard Girdle...
Black Spandex Above the Knee Compression Girdles with Contact Closure with Zipper...
Short Girdle, Mid-thigh, Front Closure...
Male Body Shaper, Front Closure...
Medicine Products: